On this page
RAX
retina and anterior neural fold homeobox
RAX is located on the long (q) arm of chromosome 18, at band 18q21.32. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 18 in the library →Available at Jeen Health
Clinical tests that include this
Overview
RAX (retina and anterior neural fold homeobox) is located on chromosome 18 and encodes a transcription factor belonging to the paired-like homeobox family. This protein plays a fundamental role in establishing the eye field during early embryogenesis and maintaining retinal progenitor populations throughout eye development. The RAX protein binds specific DNA sequences to activate or repress target genes involved in ocular tissue formation.
Pathogenic variants in RAX result in severe congenital eye malformations, including anophthalmia (absence of one or both eyes) and microphthalmia (abnormally small eyes). These conditions represent failures in the earliest stages of eye development, when the neural ectoderm commits to forming ocular structures. RAX is recognised on multiple NHS Genomic Medicine Service gene panels for structural eye disease and foetal anomalies.
What the gene does
The RAX protein functions as a sequence-specific transcription factor that regulates the developmental programme of the anterior neural plate and developing retina. During early embryonic patterning, RAX marks the eye field territory and promotes the expression of genes necessary for optic vesicle evagination from the forebrain. The protein binds to conserved DNA motifs in the regulatory regions of downstream target genes, modulating their transcriptional activity to coordinate eye development.
Within the developing retina, RAX sustains the proliferative capacity of retinal progenitor cells whilst preventing their premature differentiation into specialised cell types. This balance ensures that sufficient progenitor populations are maintained to generate the full complement of retinal neurons and glial cells. RAX also participates in establishing dorsal-ventral patterning of the optic cup and contributes to the specification of retinal pigment epithelium. The protein's activity must be precisely regulated both spatially and temporally to achieve proper eye morphogenesis.
Video: Genetics 101
Chromosome location
RAX is located on the long arm of chromosome 18 at position 21.32 (18q21.32). The gene spans a relatively compact genomic region and comprises three exons. This chromosomal region does not harbour a particularly high density of other developmental genes, though its location is stable across mammalian evolution, suggesting conserved syntenic organisation.
Protein structure
The RAX protein consists of 346 amino acids organised into several functional regions. Near the N-terminus lies an octapeptide motif spanning amino acids 33-40, a conserved sequence found in several paired-class homeobox proteins. A large disordered region extends from amino acid 46 to 145, likely providing flexibility for protein-protein interactions. The homeobox DNA-binding domain occupies amino acids 136-195, representing the protein's core functional element that recognises specific DNA sequences through its characteristic helix-turn-helix structure.
Downstream of the homeobox, another extensive disordered region spans amino acids 194-318, which may serve regulatory or scaffolding functions. The C-terminal region contains an OAR motif (amino acids 323-336), whose function remains under investigation, and a nuclear localisation signal (amino acids 329-333) that directs the protein to the nucleus where it can access chromatin and regulate transcription. This domain architecture is characteristic of developmental transcription factors, combining a conserved DNA-binding module with flexible regulatory regions.
Key variants
Pathogenic variants in RAX typically result in loss of protein function, either through premature termination, frameshift mutations, or missense changes affecting the homeobox domain. Because eye development depends critically on RAX activity during a narrow developmental window, even partial loss of function can cause severe phenotypes. The inheritance pattern varies, with both autosomal recessive and autosomal dominant cases reported, though recessive inheritance appears more common for severe anophthalmia.
No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.
Associated conditions
Variants in RAX are primarily associated with anophthalmia and microphthalmia, representing a spectrum of eye malformation severity. Anophthalmia describes the complete absence of ocular tissue, whilst microphthalmia refers to eyes with reduced overall volume. These conditions manifest at birth and may occur in isolation or alongside other developmental anomalies. The severity of the eye malformation often correlates with the degree of RAX functional impairment, though genotype-phenotype relationships remain incompletely defined for this gene.
No disease links recorded for this gene in our reference set.
UK clinical status
RAX appears on several NHS Genomic Medicine Service gene panels with green (definitive) classification. These include the Anophthalmia or Microphthalmia panel, the DDG2P (Developmental Disorders Genotype-to-Phenotype) panel, the Foetal Anomalies panel (R21), and the Structural Eye Disease panel (R36). This green status indicates strong evidence linking RAX variants to these conditions, supporting its use in NHS diagnostic testing pathways for individuals with congenital eye malformations identified prenatally or postnatally.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What inheritance pattern does RAX follow?
RAX-related eye malformations can follow either autosomal recessive or autosomal dominant inheritance patterns. Recessive inheritance is more commonly reported for severe anophthalmia, requiring pathogenic variants in both gene copies. Some variants appear to act dominantly, causing disease with a single altered copy.
Can RAX variants be detected through prenatal screening?
RAX variants can be identified through genomic sequencing if clinical findings such as anophthalmia or microphthalmia are detected on prenatal ultrasound. Foetal anomaly scanning may identify severe eye malformations during the second trimester, prompting genetic investigation that can include RAX analysis.
Are all RAX variants associated with complete absence of the eyes?
No, RAX variants produce a spectrum of eye malformation severity. Some individuals have complete anophthalmia (absent eyes), whilst others present with microphthalmia (small but present eyes). The specific variant and its effect on protein function influence phenotype severity, though prediction remains imperfect for individual cases.